Literature DB >> 9159325

Psychological impact of screening for familial ovarian cancer: reactions to initial assessment.

G Erlick Robinson1, B P Rosen, L N Bradley, W G Rockert, M L Carr, D E Cole, K J Murphy.   

Abstract

OBJECTIVES: To assess the psychological impact on women attending a familial ovarian cancer screening clinic. STUDY
METHODS: 157 women referred for screening completed an investigator designed questionnaire, the Spielberger State Trait Anxiety Scale and the Centre for Epidemiological Studies Depression Scale prior to the screening interview and an eight-item questionnaire post-assessment.
RESULTS: 95.4% saw the screening as valuable. Thirty-one point four percent of all patients scored about the cutoff point for depression. Sixteen percent exhibited high levels of anxiety. Fifty-six point four percent of patients accurately perceived their risk. Twenty-one point five percent of those who accurately perceived themselves as being at high risk had high anxiety and 40.6% reported significant depressive symptoms. Of the 26.5% of patients who overestimated their risks, 40.0% reported significant depressive symptoms and 22.6% were anxious. Of the 17.1% who minimized their risk, none were anxious (0.0%), and only 15.8% were depressed.
CONCLUSION: Attendees at a familial ovarian cancer screening clinic may have high levels of depression and anxiety.

Entities:  

Mesh:

Year:  1997        PMID: 9159325     DOI: 10.1006/gyno.1997.4686

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.

Authors:  Christine Maheu; Andrea Vodermaier; Heidi Rothenmund; Steve Gallinger; Paola Ardiles; Kara Semotiuk; Spring Holter; Saumea Thayalan; Mary Jane Esplen
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.

Authors:  Sheri A Babb; Elizabeth M Swisher; Hope N Heller; Alison J Whelan; David G Mutch; Thomas J Herzog; Janet S Rader
Journal:  J Genet Couns       Date:  2002-04       Impact factor: 2.537

4.  Women at risk of ovarian cancer: attitudes towards and expectations of the familial ovarian cancer clinic.

Authors:  R Sheppard; A Fry; R Rush; C M Steel; A Cull
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

5.  Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer.

Authors:  L Elit; M J Esplen; K Butler; S Narod
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

6.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 7.  Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer.

Authors:  Elizabeth Swisher
Journal:  Curr Treat Options Oncol       Date:  2003-04

8.  Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  L Fallowfield; A Fleissig; J Barrett; U Menon; I Jacobs; J Kilkerr; V Farewell
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

9.  Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic.

Authors:  A Cull; A Fry; R Rush; C M Steel
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

10.  The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT.

Authors:  Lesley Fallowfield; Ivonne Solis-Trapala; Usha Menon; Carolyn Langridge; Shirley May; Ian Jacobs; Valerie Jenkins
Journal:  Br J Cancer       Date:  2017-03-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.